Body dysmorphic disorder symptoms in patients with melasma

Abstract

AbstractBackgroundBody dysmorphic disorder (BDD) is a psychiatric condition characterized by extreme preoccupation with non‐existent or minor defects in appearance, disrupting daily functioning. Melasma is a common concern among BDD patients with dermatological conditions. This study aimed to estimate the incidence and characteristics of BDD in patients with melasma, and compare the psychological condition of patients and age‐ and sex‐matched healthy controls.MethodsPatients with melasma and healthy controls were screened using the BDD Questionnaire (BDDQ), Self‐rating Anxiety Scale (SAS), and Self‐rating Depression Scale (SDS). A questionnaire was administered to collect demographic information and clinical characteristics. Standard statistical tests were conducted, such as descriptive analysis, chi‐square, and nonparametric tests. The level of statistical significance for all tests was set at a P < 0.05.ResultsAmong the 470 patients with melasma included in the study, 53 were positive for BDDQ in the preliminary screening and were associated with a history of treatment, higher Melasma Area and Severity Index (MASI), and Melasma Quality of Life (MELASQoL) scores, and higher SAS and SDS scores. The positive rate of BDDQ ranged from 0.4%, using the most stringent criteria to assess melasma severity, to 11.3%, without using objective criteria. Compared to healthy controls, patients with melasma had a higher positive rate of BDDQ and higher SAS and SDS scores.ConclusionIn patients with melasma who exaggerate the severity of the disease, psychiatric treatment and the patient‐physician relationship have a positive effect. This study assessed the positive rate of BDDQ in melasma and proposed the feasibility of psychiatric treatment for patients with melasma.